3 studies found for:    17975496 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Erlotinib;   Drug: Temsirolimus
2 Completed Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Condition: Resistant Solid Malignancies
Interventions: Drug: Temsirolimus;   Drug: Docetaxel
3 Completed A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: sunitinib and rapamycin (Drug will be held)

Indicates status has not been verified in more than two years